Today: 10 June 2026
Bitcoin Price Today: Why BTC Is Stuck Between Ceasefire Relief and ETF Doubts
9 April 2026
1 min read

Bitcoin Price Today: Why BTC Is Stuck Between Ceasefire Relief and ETF Doubts

NEW YORK, April 9, 2026, 14:08 (EDT)

Bitcoin hovered close to $72,000 on Thursday, with traders digesting uncertainty around a fragile U.S.-Iran ceasefire. The cryptocurrency was last at $72,021, marking a 0.3% gain for the day.

Institutional demand remains patchy, despite Wall Street rolling out more options. On April 6, U.S. spot bitcoin ETFs pulled in $471.4 million, but by April 8, they saw $93.9 million flow out. That same day, Morgan Stanley entered the fray with MSBT, bringing in $30.6 million at launch. Its 0.14% sponsor fee undercuts both BlackRock’s IBIT and Fidelity’s FBTC, which each charge 0.25%.

Macro headlines kept driving action. Bitcoin dropped close to 1% to $70,680 earlier Thursday, Reuters said, with traders reacting to renewed strikes in Lebanon and more trouble in the Strait of Hormuz as the ceasefire came under question. The cryptocurrency later rebounded, pushing back above $72,000 during U.S. trading.

It’s in line with what’s been happening elsewhere. “The entire ceasefire remains tenuous,” Derek Halpenny, head of research global markets EMEA at MUFG, told Reuters. Bitcoin, true to form, has mostly tracked risk assets this year—moving alongside equities and rate speculation, not acting like a haven. Reuters

Morgan Stanley is pitching the launch as a way to connect traditional investors with digital assets. Ben Huneke pointed to “long-term trends in financial innovation.” Ally Wallace called exchange-traded products a “transparent and regulated framework.” Amy Oldenburg noted that clients prefer access via “structures they understand and trust.” Morgan Stanley

Washington is in focus again. Treasury Secretary Scott Bessent called on Congress to approve the Clarity Act, saying fuzzy U.S. regulations have driven crypto work overseas. A federal market-structure bill, he argued, could anchor digital-asset investment at home.

The sector showed no clear direction. Ether slipped 0.9% to $2,210.56. Strategy ticked up around 2.3%. Coinbase, though, dropped about 1.2%. Investors, it seems, continued to selectively target names instead of piling into the full group.

The trouble is, this could just be another brief relief rally. On Thursday, Reuters’ Morning Bid noted Asian equities and Wall Street futures had already surrendered some of the ground won on Wednesday. Fed officials aren’t showing urgency about lowering rates, either — a combo that threatens risk appetite if oil prices hold up and ETF demand stays weak.

Thursday’s jump still leaves bitcoin sitting roughly 43% under its record high of $126,223.18 set back in early October 2025. Right now, $72,000 doesn’t signal a breakout—more a gauge of whether buyers are willing to hang on.

Stock Market Today

  • SenSen Networks Limited (ASX:SNS) Shows Potential Undervaluation Amid Positive Earnings Outlook
    June 10, 2026, 5:44 PM EDT. SenSen Networks Limited (ASX:SNS) has experienced a 10% share price increase recently yet still trades below its yearly highs. The company's price-to-earnings (PE) ratio stands at 13.31x, significantly below the software industry average of 25.62x, suggesting potential undervaluation. SenSen's high beta indicates notable price volatility, providing additional buying opportunities. The firm's earnings growth is projected in the teens over the coming years, signaling robust future cash flows and a promising outlook. Investors may find value in accumulating more shares as the market may not fully price in this growth. However, considerations around the company's financial health remain crucial before investment decisions.

Latest articles

YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal
Previous Story

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open
Next Story

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

Go toTop